| 2008-07-01 |
Cancer Personalized Medicine 2008 |
Select Biosciences Limited |
| 2008-06-11 |
ADVENTRX Pharmaceuticals Inc: Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile |
Datamonitor |
| 2008-02-01 |
Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions |
CHI Insight Pharma Reports |
| 2007-12-13 |
Pricing and Reimbursement of Next Generation Diagnostics in the United States |
Decision Resources |
| 2007-11-01 |
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape |
CHI Insight Pharma Reports |
| 2004-10-01 |
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential |
Kalorama Information |
| 2003-09-12 |
U.S. Nucleic Acid Isolation and Purification Markets |
Frost & Sullivan |
| 2001-02-01 |
Predictive Toxicology |
AdvanceTech Monitor |
